David Moadel

David Moadel

Expertise: Stocks, Options, Precious metals, Bitcoin, Altcoins

Education: Master's degree in education from the American College of Education, Bachelor's degree in education from Florida Atlantic University, Associate's degree in liberal arts from Palm Beach Community College

About David:
David Moadel is a financial writer for InvestorPlace.com. He has a master’s degree in education and has authored financial content for multiple websites.

David is also active as a social media influencer, with tens of thousands of followers on YouTube, Twitter, StockTwits, and other popular sites. David writes on topics ranging from stocks to cryptocurrencies, options, precious metals, bonds, futures, and other areas of finance.

Focusing on data rather than emotions, David is always on the lookout for new pathways to financial freedom. Count on David for wealth-building strategies and resources for investors and traders of all financial backgrounds.

You can follow David on YouTube, Twitter, StockTwits and LinkedIn.

Recent Articles

Lucid Layoffs Won’t Save LCID Stock. Steer Clear.

Analysts' opinions of Lucid Group's headcount reduction may vary, but it's hard to build a convincing bull case for LCID stock.

Bet on a Big-Bank Blastoff With Wells Fargo Stock

WFC stock is an easy-peasy investment as Wells Fargo sidesteps housing market woes and bank-run contagion concerns.

Charles Schwab Outlook: How Much Worse Can It Get for SCHW Stock?

Schwab may survive a bank run, but SCHW stock could still lose value for a while as clients move out of cash and into higher-yielding assets.

Weather the Banking Storm With WAL Stock

Western Alliance Bancorp isn't immune to analysts' criticism, but WAL stock should gain value in 2023 despite the banking crisis.

Polestar Outlook: My PSNY Stock Price Prediction for 2025

Give PSNY stock some time to get into the fast lane, as Polestar's vehicles are sleek and powerful but also too costly for some customers.

Is Pfizer Stock a Buy, Sell or Hold? Here’s My Call.

Pfizer can't depend on Covid-19 vaccines as a revenue source in 2023, but PFE stock can still grow as the drugmaker broadens its pipeline.

Don’t Miss Out on the Biggest Bitcoin Opportunity of the Decade

Between sticky U.S. dollar inflation and the ongoing problems with conventional banks, Bitcoin is suddenly a safe haven in the markets.

Profit From the Lithium Boom With LAC Stock

LAC stock deserves a much higher re-rating as Lithium Americas breaks ground on a potentially lucrative project in Nevada.

CVX Stock Outlook: The Long-Term Case for Investing in Chevron

CVX stock should reward patient investors over the coming months as Chevron seizes an opportunity to drill in federally permitted waters.

EV Charging Play CHPT Has 100% Upside Potential. Here’s Why.

ChargePoint's revenue growth expectations suggest that patient CHPT stock investors could have a multi-bagger on their hands.